Featured updates to the NCCN guidelines

Robert J. Motzer; Eric Jonasch; M. Dror Michaelson; Lakshminarayanan Nandagopal; John L. Gore; Saby George; Ajjai Alva; Naomi Haas; Michael R. Harrison; Elizabeth R. Plimack; Jeffrey Sosman; Neeraj Agarwal; Sam Bhayani; Toni K. Choueiri; Brian A. Costello; Ithaar H. Derweesh; Thomas H. Gallagher; Steven L. Hancock; Christos Kyriakopoulos; Chad LaGrange; Elaine T. Lam; Clayton Lau; Bryan Lewis; Brandon Manley; Brittany McCreery; Andrew McDonald; Amir Mortazavi; Phillip M. Pierorazio; Lee Ponsky; Bruce G. Redman; Bradley Somer; Geoffrey Wile; Mary A. Dwyer; Lydia J. Hammond; Griselda Zuccarino-Catania

doi:10.6004/jnccn.2019.0054

Featured updates to the NCCN guidelines

Robert J. Motzer, Eric Jonasch, M. Dror Michaelson, Lakshminarayanan Nandagopal, John L. Gore, Saby George, Ajjai Alva, Naomi Haas, Michael R. Harrison, Elizabeth R. Plimack, Jeffrey Sosman, Neeraj Agarwal, Sam Bhayani, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Thomas H. Gallagher, Steven L. Hancock, Christos Kyriakopoulos, Chad LaGrangeElaine T. Lam, Clayton Lau, Bryan Lewis, Brandon Manley, Brittany McCreery, Andrew McDonald, Amir Mortazavi, Phillip M. Pierorazio, Lee Ponsky, Bruce G. Redman, Bradley Somer, Geoffrey Wile, Mary A. Dwyer, Lydia J. Hammond, Griselda Zuccarino-Catania

School of Medicine

Research output: Contribution to journal › Review article › peer-review

66 Scopus citations

Abstract

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal cell carcinoma, and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize the NCCN Kidney Cancer Panel discussions for the 2020 update to the guidelines regarding initial management and first-line systemic therapy options for patients with advanced clear cell renal cell carcinoma.

Original language	English (US)
Pages (from-to)	1278-1285
Number of pages	8
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	17
Issue number	11
DOIs	https://doi.org/10.6004/jnccn.2019.0054
State	Published - 2019

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2019.0054

Cite this

Motzer, R. J., Jonasch, E., Dror Michaelson, M., Nandagopal, L., Gore, J. L., George, S., Alva, A., Haas, N., Harrison, M. R., Plimack, E. R., Sosman, J., Agarwal, N., Bhayani, S., Choueiri, T. K., Costello, B. A., Derweesh, I. H., Gallagher, T. H., Hancock, S. L., Kyriakopoulos, C., ... Zuccarino-Catania, G. (2019). Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 17(11), 1278-1285. https://doi.org/10.6004/jnccn.2019.0054

Motzer, RJ, Jonasch, E, Dror Michaelson, M, Nandagopal, L, Gore, JL, George, S, Alva, A, Haas, N, Harrison, MR, Plimack, ER, Sosman, J, Agarwal, N, Bhayani, S, Choueiri, TK, Costello, BA, Derweesh, IH, Gallagher, TH, Hancock, SL, Kyriakopoulos, C, LaGrange, C, Lam, ET, Lau, C, Lewis, B, Manley, B, McCreery, B, McDonald, A, Mortazavi, A, Pierorazio, PM, Ponsky, L, Redman, BG, Somer, B, Wile, G, Dwyer, MA, Hammond, LJ & Zuccarino-Catania, G 2019, 'Featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 17, no. 11, pp. 1278-1285. https://doi.org/10.6004/jnccn.2019.0054

@article{462d554152ec450f8b5b0db430b83f5c,

title = "Featured updates to the NCCN guidelines",

abstract = "The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal cell carcinoma, and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize the NCCN Kidney Cancer Panel discussions for the 2020 update to the guidelines regarding initial management and first-line systemic therapy options for patients with advanced clear cell renal cell carcinoma.",

author = "Motzer, {Robert J.} and Eric Jonasch and {Dror Michaelson}, M. and Lakshminarayanan Nandagopal and Gore, {John L.} and Saby George and Ajjai Alva and Naomi Haas and Harrison, {Michael R.} and Plimack, {Elizabeth R.} and Jeffrey Sosman and Neeraj Agarwal and Sam Bhayani and Choueiri, {Toni K.} and Costello, {Brian A.} and Derweesh, {Ithaar H.} and Gallagher, {Thomas H.} and Hancock, {Steven L.} and Christos Kyriakopoulos and Chad LaGrange and Lam, {Elaine T.} and Clayton Lau and Bryan Lewis and Brandon Manley and Brittany McCreery and Andrew McDonald and Amir Mortazavi and Pierorazio, {Phillip M.} and Lee Ponsky and Redman, {Bruce G.} and Bradley Somer and Geoffrey Wile and Dwyer, {Mary A.} and Hammond, {Lydia J.} and Griselda Zuccarino-Catania",

year = "2019",

doi = "10.6004/jnccn.2019.0054",

language = "English (US)",

volume = "17",

pages = "1278--1285",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "11",

}

TY - JOUR

T1 - Featured updates to the NCCN guidelines

AU - Motzer, Robert J.

AU - Jonasch, Eric

AU - Dror Michaelson, M.

AU - Nandagopal, Lakshminarayanan

AU - Gore, John L.

AU - George, Saby

AU - Alva, Ajjai

AU - Haas, Naomi

AU - Harrison, Michael R.

AU - Plimack, Elizabeth R.

AU - Sosman, Jeffrey

AU - Agarwal, Neeraj

AU - Bhayani, Sam

AU - Choueiri, Toni K.

AU - Costello, Brian A.

AU - Derweesh, Ithaar H.

AU - Gallagher, Thomas H.

AU - Hancock, Steven L.

AU - Kyriakopoulos, Christos

AU - LaGrange, Chad

AU - Lam, Elaine T.

AU - Lau, Clayton

AU - Lewis, Bryan

AU - Manley, Brandon

AU - McCreery, Brittany

AU - McDonald, Andrew

AU - Mortazavi, Amir

AU - Pierorazio, Phillip M.

AU - Ponsky, Lee

AU - Redman, Bruce G.

AU - Somer, Bradley

AU - Wile, Geoffrey

AU - Dwyer, Mary A.

AU - Hammond, Lydia J.

AU - Zuccarino-Catania, Griselda

PY - 2019

Y1 - 2019

N2 - The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal cell carcinoma, and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize the NCCN Kidney Cancer Panel discussions for the 2020 update to the guidelines regarding initial management and first-line systemic therapy options for patients with advanced clear cell renal cell carcinoma.

AB - The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal cell carcinoma, and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize the NCCN Kidney Cancer Panel discussions for the 2020 update to the guidelines regarding initial management and first-line systemic therapy options for patients with advanced clear cell renal cell carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=85075500785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075500785&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2019.0054

DO - 10.6004/jnccn.2019.0054

M3 - Review article

C2 - 31693980

AN - SCOPUS:85075500785

SN - 1540-1405

VL - 17

SP - 1278

EP - 1285

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 11

ER -

Featured updates to the NCCN guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this